Nasal Spray Protects Against All Flu Strains in Trial

Imagine a future where flu pandemics can't catch us off guard because we already have a universal shield in place.

Scientists have tested a nasal spray in 143 people that protects against every known flu strain, from the 1933 virus still circulating today to the bird flu that infected people in China in 2013. The spray delivered an antibody called CR9114 directly into participants' noses twice daily without causing serious side effects.

The breakthrough comes from a clever rethinking of where we fight the flu. When researchers first injected this special antibody into animals' bloodstreams, it barely worked. Too little reached the nose, where flu viruses actually invade our bodies.

Leyden Labs solved that problem by putting the antibody exactly where it's needed most. The nasal spray keeps steady levels of protection right at flu's main entry point.

What makes this antibody different from annual flu vaccines is its target. Regular vaccines train our immune systems to recognize flu strains that changed last year, which is why they only work moderately well. CR9114 latches onto a part of the flu virus that never changes, no matter how much the rest of it mutates.

The spray already stopped mice and monkeys from getting sick when exposed to both influenza A and B strains. Now human nasal mucus samples collected after spray use successfully neutralized multiple flu types in lab tests.

Researchers still need to expose people using the spray to actual flu viruses to confirm it prevents illness in real-world conditions. Linda Wakim from the University of Melbourne notes the virus could potentially enter through the mouth, so protection might not be perfect.

Why This Inspires

This isn't just another incremental improvement to flu season. It's a completely new approach that could protect healthcare workers on pandemic frontlines and shield immunocompromised people who can't rely on regular vaccines.

The twice-daily routine requires more effort than a single annual shot, but that's a small price for protection against flu strains we haven't even encountered yet. When the next pandemic threat emerges from animal populations, we might already have our defenses in place while vaccines are still being developed.

The science shows us that sometimes the best solutions come from changing our approach entirely, not just improving what already exists.